Skip to content
ScienceBlog.com
  • Our Bloggers
  • Twitter
  • Google News
  • Substack
  • FaceBook
  • Contribute/Contact
  • Search

texas md anderson

Protein wields phosphate group to inhibit cancer metastasis

ScienceBlog.com

HOUSTON – By sticking a chemical group to it at a specific site, a protein arrests an enzyme that may worsen and spread cancer, an international research team led by scientists at The University of Texas MD Anderson Cancer Center reports in …

Categories Blog Entry, Health

Drugs are safe, active in patients normally ineligible for clinical trial

ScienceBlog.com

ORLANDO – A two-drug combination is safe and active in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome patients who are usually excluded from clinical trials because they have other illnesses or poor performance status -…

Categories Blog Entry, Health

Wellness programs provide high returns, research reveals

ScienceBlog.com

Employee wellness programs have often been viewed as a nice extra, not a strategic imperative. But the data demonstrate otherwise, according to a team of researchers led by Leonard L. Berry of Texas A&M University, Ann M. Mirabito of Baylor Universi…

Categories Blog Entry, Health

Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies

ScienceBlog.com

BOSTON – Researchers have identified an important signaling pathway that, when blocked, significantly decreases the spread of pediatric bone cancer.
In their study, researchers at The University of Texas MD Anderson Children’s Cancer Hospital…

Categories Blog Entry, Health

Researchers find better method to help mothers cope with child’s cancer and related stress

ScienceBlog.com

BOSTON – Mothers who have children diagnosed with cancer now have a better approach to address and cope with stresses associated with their child’s disease.
A new certified intervention has proven to be more effective long term compared to ot…

Categories Blog Entry, Brain & Behavior, Health

Vaccine extends glioblastoma patients’ survival in phase II trial

ScienceBlog.com

HOUSTON – A vaccine that turns the immune system against brain tumor cells bearing a genetic mutation that drives the most aggressive form of glioblastoma multiforme improved survival of patients in a phase II clinical trial, researchers at Duke…

Categories Blog Entry, Brain & Behavior, Health

Bloggers

  • Green shrubsWeeding the Knots
  • Campaign underway to discourage diesel-engine tampering
  • Trains in the automotive age: Why shrinking the rail physical plant si…
  • Energy-tied carbon emissions drop 25-38% below 2005 levels by 2030, EI…
  • Lemon peel, flax fibres hold keys to eco-friendly car parts
  • Dance and games offer glimpses of life – and death – in ancient Italy

Archives

© 2023 ScienceBlog.com | Follow our RSS / XML feed